Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

South Asian Women & Yoga Education Study (SAWYES)

16. november 2012 oppdatert av: Dr. Amandah Hoogbruin, Kwantlen Polytechnic University

Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Studieoversikt

Status

Ukjent

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Forventet)

50

Fase

  • Fase 1

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • British Columbia
      • Surrey, British Columbia, Canada, V3T 0G9
        • Rekruttering
        • The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
        • Ta kontakt med:
        • Ta kontakt med:
      • Surrey, British Columbia, Canada, V3W 2M8
        • Har ikke rekruttert ennå
        • Kwantlen Polytechnic University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amandah L Hoogbruin, PhD

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

40 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • 40- 65 years old
  • Postmenopausal (amenorrhea for ≥ 12 months)
  • Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
  • Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
  • Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
  • Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.

Exclusion Criteria:

  • Have had a period within the last year
  • Are not between the ages of 40 and 65
  • Have experience with yoga within the last 12 months
  • Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
  • Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
  • Have a severe infectious or other medical illness right now such as pneumonia
  • Use medications to lower blood sugar levels
  • Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
  • Regularly use an assistive device (e.g., cane, walker) to walk

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Styre
Eksperimentell: Yoga intervensjon
12 week 90 minute hatha yoga session offered three (3x) per week. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in blood pressure
Tidsramme: baseline, at end of study (12 wks), & 3 months post-study
blood pressure is measured as a specific physiologic index of cardiovascular risk.
baseline, at end of study (12 wks), & 3 months post-study

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in subjective well-being
Tidsramme: baseline, at end of study (12 wks), & 3 months post-study
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
baseline, at end of study (12 wks), & 3 months post-study
Change in perceived physical well-being
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
baseline, end of study (12 wks) & 3 months post-study
Change in insulin sensitivity
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in inflammation
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum total cholesterol
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Serum total cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum high-density lipoprotein (HDL) cholesterol
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum low-density lipoprotein (LDL) cholesterol
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum triglycerides
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Serum triglycerides will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in waist circumference.
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change waist-hip ratio
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in body mass index (BMI)
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in resting heart rate
Tidsramme: baseline, end of study (12 wks) & 3 months post-study
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in heart rate
Tidsramme: baseline, at end of study (12 wks), & 3 months post-study
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
baseline, at end of study (12 wks), & 3 months post-study

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Amandah L Hoogbruin, PhD, Kwantlen Polytechnic University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. november 2012

Primær fullføring (Forventet)

1. desember 2014

Studiet fullført (Forventet)

1. august 2015

Datoer for studieregistrering

Først innsendt

17. juni 2012

Først innsendt som oppfylte QC-kriteriene

14. august 2012

Først lagt ut (Anslag)

17. august 2012

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

19. november 2012

Siste oppdatering sendt inn som oppfylte QC-kriteriene

16. november 2012

Sist bekreftet

1. november 2012

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • KK11-04

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere